What is WGSWW's health score?

GeneDx Holdings Corp. (WGSWW) has a TradeApes health score of 47 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is WGSWW's estimated fair value?

Based on our 5-year discounted cash flow model, GeneDx Holdings Corp.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is WGSWW undervalued or overvalued?

Our model currently rates WGSWW as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for WGSWW... Refresh in a moment for the full analysis.

GeneDx Holdings Corp. (WGSWW)

Healthcare Fair Value High mixed

Updated: 2026-04-21

TradeApes Score

hold

Financial Strength

55 Mixed

Operating Trend

30 Weak

Relative Value

40 Weak

Capital Allocation

60 Healthy

Risk

70 Healthy

Key Findings

+ Active debt paydown — total debt declining more than 10% year over year

Unlock Full Report →

− Revenue declining — sales down 5–15% year over year

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.